title: Glutathione status and the renal elimination of inorganic mercury in the Mrp2(-/-) mouse.
abstract: Multidrug resistance-associated proteins (MRP) 2 and 4 are localized in proximal tubular epithelial cells and participate in the renal elimination of xenobiotics. MRP2 has also been implicated in the renal and hepatic elimination of mercury. The current study tested the hypothesis that MRP2 and MRP4 are involved in renal and hepatic handling of inorganic mercury (Hg(2+)). We examined the disposition of Hg(2+) in Mrp2(-/-) mice and assessed the transport of mercuric conjugates in inside-out membrane vesicles containing human MRP4. Since MRP2 has been shown to utilize glutathione (GSH) for transport of select substrates, we examined renal concentrations of GSH and cysteine and the expression of glutamate cysteine ligase (GCL) in Mrp2(-/-) and FVB mice. The effect of Hg(2+) exposure on renal GSH levels was also assessed in these mice. Our data suggest that MRP2, but not MRP4, is involved in proximal tubular export of Hg(2+). In addition, GSH levels are greater in Mrp2(-/-) mice and exposure to Hg(2+) reduced renal levels of GSH. Expression of GCL was also altered in Mrp2(-/-) mice under normal conditions and following exposure to HgCl2. This study provides important novel data regarding the transport of Hg(2+) and the effect of Hg(2+) exposure on GSH levels.
authors.affiliation: Mercer University School of Medicine, Division of Basic Medical Sciences, Macon, Georgia, United States of America.
authors.forename: Christy C
authors.initials: CC
authors.lastname: Bridges
authors.forename: Lucy
authors.initials: L
authors.lastname: Joshee
authors.forename: Jeroen J M W
authors.initials: JJ
authors.lastname: van den Heuvel
authors.forename: Frans G M
authors.initials: FG
authors.lastname: Russel
authors.forename: Rudolfs K
authors.initials: RK
authors.lastname: Zalups
mesh_terms: D000818:Animals; D001692:Biological Transport; D002413:Cations, Divalent / Q000378:metabolism; D003545:Cysteine / Q000378:metabolism; D005260:Female; D017353:Gene Deletion; D005978:Glutathione / Q000378:metabolism*; D006801:Humans; D007668:Kidney / Q000378:metabolism*; D007684:Kidney Tubules / Q000378:metabolism; D008628:Mercury / Q000032:analysis / Q000378:metabolism*; D051379:Mice; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000235:genetics* / Q000378:metabolism*
chemical_list: D002413:Cations, Divalent; D003545:Cysteine; D005978:Glutathione; D008628:Mercury; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins; C000715087:ABCC2 protein, human; C073492:ABCC4 protein, human
references.citation: J Pharmacol Exp Ther. 2008 Jan;324(1):383-90
references.pmid: 17940195
references.citation: Biofactors. 2009 Nov-Dec;35(6):500-8
references.pmid: 19904718
references.citation: Pharmacol Rev. 2000 Mar;52(1):113-43
references.pmid: 10699157
references.citation: J Pharmacol Exp Ther. 1990 Sep;254(3):962-70
references.pmid: 2395124
references.citation: J Nucl Med. 1985 Jan;26(1):72-6
references.pmid: 3965655
references.citation: Methods Enzymol. 1987;143:101-9
references.pmid: 3657520
references.citation: Toxicol Appl Pharmacol. 2011 Feb 15;251(1):50-8
references.pmid: 21134393
references.citation: Toxicol Sci. 2008 Sep;105(1):211-20
references.pmid: 18511429
references.citation: Environ Toxicol Pharmacol. 2008 Jul;26(1):102-8
references.pmid: 21783896
references.citation: J Pharmacol Exp Ther. 2006 May;317(2):579-89
references.pmid: 16421286
references.citation: Life Sci. 1996;59(15):1237-46
references.pmid: 8845010
references.citation: Biochem Pharmacol. 1995 Nov 9;50(10):1719-24
references.pmid: 7503776
references.citation: Mol Pharmacol. 1999 Oct;56(4):714-9
references.pmid: 10496953
references.citation: J Am Soc Nephrol. 2002 Mar;13(3):595-603
references.pmid: 11856762
references.citation: Curr Med Chem. 2008;15(20):1981-2039
references.pmid: 18691054
references.citation: J Am Soc Nephrol. 1999 Jun;10(6):1159-69
references.pmid: 10361853
references.citation: Biometals. 2011 Oct;24(5):857-74
references.pmid: 21424617
references.citation: Arch Biochem Biophys. 1992 Jul;296(1):350-3
references.pmid: 1351382
references.citation: Health Phys. 2001 Feb;80(2 Suppl):S28-30
references.pmid: 11197511
references.citation: J Pharmacol Exp Ther. 2007 Jan;320(1):229-35
references.pmid: 17005917
references.citation: J Steroid Biochem Mol Biol. 2005 Dec;97(4):369-75
references.pmid: 16150593
references.citation: J Am Soc Nephrol. 2004 Mar;15(3):663-73
references.pmid: 14978168
references.citation: J Toxicol Environ Health B Crit Rev. 2010;13(5):385-410
references.pmid: 20582853
references.citation: Mol Aspects Med. 2009 Feb-Apr;30(1-2):86-98
references.pmid: 18812186
references.citation: Toxicol Appl Pharmacol. 1996 Sep;140(1):180-7
references.pmid: 8806884
references.citation: J Inorg Biochem. 2012 Mar;108:141-9
references.pmid: 22197475
references.citation: Mol Pharmacol. 1999 May;55(5):929-37
references.pmid: 10220572
references.citation: Toxicology. 1998 Feb 20;126(1):23-31
references.pmid: 9585089
references.citation: Proc Natl Acad Sci U S A. 1987 Nov;84(21):7735-8
references.pmid: 2444983
references.citation: J Pharmacol Exp Ther. 2005 Nov;315(2):534-44
references.pmid: 16079298
references.citation: Toxicol Appl Pharmacol. 1996 Nov;141(1):59-67
references.pmid: 8917676